Clay Roscoe, M.D. M.Sc.

Chief Medical Officer

Dr. Roscoe was appointed to Sedia’s Executive Team as Chief Medical Officer in January 2021 after working for Sedia as a Medical Advisor since November 2018. He worked as an HIV clinician and public health specialist for 17 years and is board-certified in Family Medicine. Dr. Roscoe provides medical guidance to Sedia on the diagnosis HIV and other communicable conditions, including in the setting of PEPFAR-supported programs in Africa. He also assists with the identification of new market opportunities, contributes to sales force and regulatory affairs efforts, and oversees ongoing Sedia clinical trials. He has worked in Namibia, Southern Africa, both for the University of Washington Department of Global Health (I-TECH) and the U.S. Centers for Disease Control and Prevention, and has extensive clinical and public health experience in HIV, tuberculosis, communicable/noncommunicable conditions, and public health preparedness for SARS-CoV-2. He received his medical degree from the Perelman School of Medicine at the University of Pennsylvania and has a Master’s in Science in Public Health from the London School of Hygiene and Tropical Medicine.


Want to know more or have any questions? Send us a message!

This field is for validation purposes and should be left unchanged.